<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_serum" title="Serum Level and Activity of Butylcholinesterase: A Biomarker for Post-Stroke Dementia" shortTitle="serum" author="Yi-Chun Chen, Wen-Hai Chou, Chiu-Ping Fang, Tung-Hsia Liu, Hsiao-Hui Tsou, Yun Wang, Yu-Li Liu" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2077-0383/8/11/1778/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
1.	LS	1.
Introduction	NN	introduction
</s>
</head>
<p>
<s type="decl">
Stroke	NN	stroke
is	VBZ	be
a	DT	a
major	JJ	major
cause	NN	cause
of	IN	of
dementia	NN	dementia
,	,	,
especially	RB	especially
in	IN	in
the	DT	the
elderly	JJ	elderly
.	.	.
</s>
<s type="decl">
Specifically	RB	specifically
,	,	,
the	DT	the
one-year	JJ	one-year
post-stroke	JJ	post-stroke
dementia	NN	dementia
(	-LRB-	(
PSD	NNP	PSD
)	-RRB-	)
rates	NNS	rate
after	IN	after
first-ever	JJ	first-ever
and	CC	and
recurrent	JJ	recurrent
stroke	NN	stroke
are	VBP	be
approximately	RB	approximately
10	CD	10
%	NN	%
and	CC	and
30	CD	30
%	NN	%
,	,	,
respectively	RB	respectively
.	.	.
</s>
<s type="decl">
Neuropathological	JJ	Neuropathological
studies	NNS	study
into	IN	into
Alzheimer	NNP	Alzheimer
’s	POS	's
disease	NN	disease
(	-LRB-	(
AD	NNP	AD
)	-RRB-	)
have	VBP	have
shown	VBN	show
that	IN	that
AD	NN	ad
pathology	NN	pathology
is	VBZ	be
often	RB	often
concomitant	JJ	concomitant
with	IN	with
ischemic	JJ	ischemic
lesions	NNS	lesion
in	IN	in
the	DT	the
elderly	JJ	elderly
.	.	.
</s>
<s type="decl">
For	IN	for
instance	NN	instance
,	,	,
evidence	NN	evidence
from	IN	from
the	DT	the
Nun	NNP	Nun
Study	NNP	Study
showed	VBD	show
that	IN	that
lacunes	NNS	lacune
increase	VBP	increase
the	DT	the
risk	NN	risk
of	IN	of
clinical	JJ	clinical
expression	NN	expression
of	IN	of
cognitive	JJ	cognitive
impairment	NN	impairment
more	JJR	more
than	IN	than
20	CD	20
times	NNS	time
during	IN	during
early	JJ	early
Braak	NNP	Braak
stages	NNS	stage
that	WDT	that
were	VBD	be
yet	RB	yet
sufficient	JJ	sufficient
to	TO	to
produce	VB	produce
dementia	NN	dementia
symptoms	NNS	symptom
.	.	.
</s>
<s type="decl">
It	PRP	it
follows	VBZ	follow
that	IN	that
vascular	JJ	vascular
insults	NNS	insult
enhance	VBP	enhance
the	DT	the
clinical	JJ	clinical
expression	NN	expression
of	IN	of
AD	NN	ad
pathology	NN	pathology
.	.	.
</s>
<s type="decl">
Vascular	JJ	Vascular
dementia	NN	dementia
is	VBZ	be
more	RBR	more
prevalent	JJ	prevalent
in	IN	in
men	NNS	man
and	CC	and
in	IN	in
populations	NNS	population
affected	VBN	affect
by	IN	by
cerebral	JJ	cerebral
small-vessel	JJ	small-vessel
disease	NN	disease
,	,	,
including	VBG	include
Asians	NNPS	Asian
,	,	,
Hispanics	NNPS	Hispanics
,	,	,
and	CC	and
Africans	NNPS	African
.	.	.
</s>
</p>
<p>
<s type="decl">
The	DT	the
cholinergic	JJ	cholinergic
system	NN	system
is	VBZ	be
distributed	VBN	distribute
throughout	IN	throughout
the	DT	the
central	JJ	central
nervous	JJ	nervous
system	NN	system
,	,	,
playing	VBG	play
a	DT	a
role	NN	role
in	IN	in
neurotransmission	NN	neurotransmission
and	CC	and
possibly	RB	possibly
mediating	VBG	mediate
various	JJ	various
neuroprotective	JJ	neuroprotective
functions	NNS	function
.	.	.
</s>
<s type="decl">
Furthermore	RB	furthermore
,	,	,
cholinergic	JJ	cholinergic
neurotransmission	NN	neurotransmission
regulates	VBZ	regulate
the	DT	the
immune	JJ	immune
response	NN	response
during	IN	during
inflammation	NN	inflammation
,	,	,
in	IN	in
a	DT	a
pathway	NN	pathway
that	WDT	that
involves	VBZ	involve
nicotinic	JJ	nicotinic
acetylcholine	NN	acetylcholine
receptors	NNS	receptor
(	-LRB-	(
nAChRs	NNS	nachr
)	-RRB-	)
and	CC	and
inhibits	VBZ	inhibit
peripheral	JJ	peripheral
cytokine	NN	cytokine
release	NN	release
.	.	.
</s>
<s type="decl">
In	IN	in
particular	JJ	particular
,	,	,
the	DT	the
efferent	JJ	efferent
vagus	NN	vagus
nerve	NN	nerve
may	MD	may
release	VB	release
acetylcholine	NN	acetylcholine
(	-LRB-	(
Ach	NNP	Ach
)	-RRB-	)
,	,	,
which	WDT	which
subsequently	RB	subsequently
binds	VBZ	bind
with	IN	with
macrophage	NN	macrophage
receptors	NNS	receptor
and	CC	and
therefore	RB	therefore
may	MD	may
inhibit	VB	inhibit
the	DT	the
release	NN	release
of	IN	of
inflammatory	JJ	inflammatory
factors	NNS	factor
after	IN	after
stroke	NN	stroke
.	.	.
</s>
<s type="decl">
In	IN	in
addition	NN	addition
to	IN	to
inflammation	NN	inflammation
,	,	,
excitotoxicity	NN	excitotoxicity
and	CC	and
energy	NN	energy
failure	NN	failure
following	VBG	follow
cerebral	JJ	cerebral
ischemia	NN	ischemia
may	MD	may
also	RB	also
initiate	VB	initiate
intracellular	JJ	intracellular
death	NN	death
pathways	NNS	pathway
and	CC	and
oxidative	NN	oxidative
stress	NN	stress
(	-LRB-	(
OS	NN	OS
)	-RRB-	)
.	.	.
</s>
<s type="decl">
The	DT	the
structural	JJ	structural
and	CC	and
functional	JJ	functional
changes	NNS	change
caused	VBN	cause
by	IN	by
OS	NNP	OS
led	VBD	lead
to	IN	to
cholinergic	JJ	cholinergic
and	CC	and
other	JJ	other
cellular	JJ	cellular
damage	NN	damage
.	.	.
</s>
<s type="decl">
Cholinergic	JJ	Cholinergic
deficit	NN	deficit
further	RBR	far
caused	VBD	cause
brain	NN	brain
atrophy	NN	atrophy
and	CC	and
finally	RB	finally
resulted	VBD	result
in	IN	in
cognitive	JJ	cognitive
impairment	NN	impairment
.	.	.
</s>
<s type="decl">
Anticholinergic	JJ	Anticholinergic
agents	NNS	agent
have	VBP	have
been	VBN	be
shown	VBN	show
to	TO	to
regulate	VB	regulate
OS	NN	OS
and	CC	and
alleviate	VB	alleviate
apoptosis	NN	apoptosis
.	.	.
</s>
<s type="sub">
Therefore	RB	therefore
,	,	,
a	DT	a
key	JJ	key
role	NN	role
in	IN	in
the	DT	the
pathogenesis	NN	pathogenesis
of	IN	of
stroke	NN	stroke
and	CC	and
dementia	NN	dementia
may	MD	may
be	VB	be
attributed	VBN	attribute
to	IN	to
OS	NNP	OS
.	.	.
</s>
</p>
<p>
<s type="decl">
Cholinergic	JJ	Cholinergic
dysfunction	NN	dysfunction
is	VBZ	be
related	JJ	related
to	IN	to
vascular	JJ	vascular
dementia	NN	dementia
.	.	.
</s>
<s type="decl">
Specifically	RB	specifically
,	,	,
Ach	NN	ach
levels	NNS	level
in	IN	in
the	DT	the
cerebrospinal	JJ	cerebrospinal
fluid	NN	fluid
are	VBP	be
up	IN	up
to	IN	to
49	CD	49
%	NN	%
lower	JJR	low
in	IN	in
patients	NNS	patient
with	IN	with
small-vessel	JJ	small-vessel
vascular	JJ	vascular
dementia	NN	dementia
than	IN	than
in	IN	in
control	NN	control
patients	NNS	patient
,	,	,
suggesting	VBG	suggest
that	IN	that
cholinergic	JJ	cholinergic
agents	NNS	agent
or	CC	or
cholinesterase	NN	cholinesterase
inhibitors	NNS	inhibitor
,	,	,
both	DT	both
of	IN	of
which	WDT	which
increase	VBP	increase
the	DT	the
Ach	NNP	Ach
level	NN	level
,	,	,
could	MD	could
be	VB	be
used	VBN	use
to	TO	to
treat	VB	treat
such	JJ	such
patients	NNS	patient
.	.	.
</s>
<s type="decl">
One	CD	one
pilot	NN	pilot
study	NN	study
showed	VBD	show
that	IN	that
acetylcholinesterase	NN	acetylcholinesterase
(	-LRB-	(
AChE	NNP	AChE
)	-RRB-	)
inhibitor	NN	inhibitor
promoted	VBD	promote
functional	JJ	functional
recovery	NN	recovery
in	IN	in
elderly	JJ	elderly
patients	NNS	patient
with	IN	with
cognitive	JJ	cognitive
impairment	NN	impairment
who	WP	who
had	VBD	have
suffered	VBN	suffer
stroke	NN	stroke
.	.	.
</s>
<s type="decl">
In	IN	in
a	DT	a
rat	NN	rat
model	NN	model
of	IN	of
chronic	JJ	chronic
ischemic	NN	ischemic
,	,	,
AChE	NNP	AChE
activity	NN	activity
was	VBD	be
slightly	RB	slightly
decreased	VBN	decrease
in	IN	in
the	DT	the
frontal	JJ	frontal
cortex	NN	cortex
,	,	,
but	CC	but
muscarinic	JJ	muscarinic
acetylcholine	NN	acetylcholine
receptor	NN	receptor
M1	NNP	M1
was	VBD	be
gradually	RB	gradually
depleted	VBN	deplete
in	IN	in
cerebral	JJ	cerebral
cortex	NN	cortex
,	,	,
striatum	NN	striatum
and	CC	and
hippocampus	NN	hippocampus
that	WDT	that
are	VBP	be
involved	VBN	involve
in	IN	in
cognitive	JJ	cognitive
function	NN	function
.	.	.
</s>
<s type="decl">
In	IN	in
addition	NN	addition
,	,	,
in	IN	in
stroke	NN	stroke
patients	NNS	patient
,	,	,
reduced	VBN	reduce
AChE	NN	AChE
activity	NN	activity
was	VBD	be
correlated	VBN	correlate
with	IN	with
lower	JJR	low
survival	NN	survival
rate	NN	rate
.	.	.
</s>
<s type="decl">
Taken	VBN	take
together	RB	together
,	,	,
these	DT	this
results	NNS	result
suggest	VBP	suggest
that	IN	that
AChE	NN	AChE
dysfunction	NN	dysfunction
is	VBZ	be
a	DT	a
result	NN	result
of	IN	of
stroke	NN	stroke
rather	RB	rather
than	IN	than
a	DT	a
cause	NN	cause
for	IN	for
further	JJR	further
neurodegeneration	NN	neurodegeneration
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
AChE	NN	AChE
inhibitors	NNS	inhibitor
exert	VBP	exert
no	DT	no
effect	NN	effect
on	IN	on
stroke	NN	stroke
risk	NN	risk
in	IN	in
dementia	NN	dementia
patients	NNS	patient
.	.	.
</s>
<s type="decl">
These	DT	this
observations	NNS	observation
suggest	VBP	suggest
that	IN	that
Ach	NNP	Ach
and	CC	and
AChE	NN	AChE
function	NN	function
may	MD	may
predict	VB	predict
post-stroke	JJ	post-stroke
neuronal	JJ	neuronal
damage	NN	damage
.	.	.
</s>
<s type="decl">
To	IN	to
date	NN	date
,	,	,
only	RB	only
a	DT	a
few	JJ	few
blood	NN	blood
biomarkers	NNS	biomarker
for	IN	for
predicting	VBG	predict
PSD	NNP	PSD
have	VBP	have
been	VBN	be
examined	VBN	examine
(	-LRB-	(
e.g.	FW	e.g.
,	,	,
D-amino	NN	d-amino
acid	NN	acid
oxidase	NN	oxidase
,	,	,
β-secretase	NN	β-secretase
,	,	,
and	CC	and
inflammation	NN	inflammation
markers	NNS	marker
)	-RRB-	)
,	,	,
and	CC	and
few	JJ	few
studies	NNS	study
have	VBP	have
focused	VBN	focus
on	IN	on
changes	NNS	change
in	IN	in
blood	NN	blood
cholinesterase	NN	cholinesterase
(	-LRB-	(
ChE	NNP	ChE
)	-RRB-	)
levels	NNS	level
and	CC	and
activity	NN	activity
in	IN	in
patients	NNS	patient
with	IN	with
PSD	NNP	PSD
.	.	.
</s>
<s type="decl">
Since	IN	since
plasma	NN	plasma
Ach	NNP	Ach
is	VBZ	be
metabolized	VBN	metabolize
by	IN	by
AChE	NNP	AChE
and	CC	and
butylcholinesterase	NN	butylcholinesterase
(	-LRB-	(
BChE	NNP	BChE
)	-RRB-	)
,	,	,
the	DT	the
present	JJ	present
study	NN	study
examined	VBD	examine
the	DT	the
functional	JJ	functional
activities	NNS	activity
of	IN	of
these	DT	this
two	CD	2
enzymes	NNS	enzyme
in	IN	in
a	DT	a
population	NN	population
of	IN	of
patients	NNS	patient
with	IN	with
chronic	JJ	chronic
ischemic	JJ	ischemic
stroke	NN	stroke
(	-LRB-	(
IS	NNP	be
)	-RRB-	)
.	.	.
</s>
</p>
</text>